US Patent 7771730 Methods and reagents for diagnosing hantavirus infection

Patent 7771730 was granted and assigned to Novartis on August, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

77717300

Patent Inventor Names

Sergio Pichuantes0

Steve H. Nguyen0

Date of Patent

August 10, 2010

Patent Application Number

116297990

Date Filed

May 24, 2005

Patent Primary Examiner

‌

Stacy B. Chen

Patent abstract

Novel methods and immunodiagnostic test kits for the detection of hantavirus infection are disclosed. The methods and kits employ combinations of recombinant N and/or G1 antigens from at least six different hantavirus serotypes, including Hantaan (HTNV), Puumala (PUUV), Seoul (SEOV), Dobrava (DOBV), Sin Nombre (SNV) and Andes (ANDV). Additional hantavirus antigens from these and other hantavirus types may also be present. The methods provide for highly accurate results and allow the detection of infection so that treatment can be administered and death avoided.